BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37116148)

  • 1. Implication of Dynamin-2 (DNM2) Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
    Sobh M; Aref S; Al Agdar M; El Zafrany M; El-Sokkary AMA
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1257-1264. PubMed ID: 37116148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel dynamin 2 mutations in adult T-cell acute lymphoblastic leukemia.
    Ge Z; Li M; Zhao G; Xiao L; Gu Y; Zhou X; Yu MD; Li J; Dovat S; Song C
    Oncol Lett; 2016 Oct; 12(4):2746-2751. PubMed ID: 27698851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia.
    Ge Z; Gu Y; Han Q; Zhao G; Li M; Li J; Chen B; Sun T; Dovat S; Gale RP; Song C
    Sci Rep; 2016 Nov; 6():38004. PubMed ID: 27885263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling.
    Tremblay CS; Brown FC; Collett M; Saw J; Chiu SK; Sonderegger SE; Lucas SE; Alserihi R; Chau N; Toribio ML; McCormack MP; Chircop M; Robinson PJ; Jane SM; Curtis DJ
    Leukemia; 2016 Oct; 30(10):1993-2001. PubMed ID: 27118408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.
    Heesch S; Goekbuget N; Stroux A; Tanchez JO; Schlee C; Burmeister T; Schwartz S; Blau O; Keilholz U; Busse A; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
    Haematologica; 2010 Jun; 95(6):942-9. PubMed ID: 20435628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
    Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
    Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of NOTCH1 mutations détections in T-acute lymphoblastic leukemia patients.
    Aref S; El Agdar M; Salama O; Zeid TA; Sabry M
    Cancer Biomark; 2020; 27(2):157-162. PubMed ID: 31796666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
    Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
    J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease.
    Fabrizi GM; Ferrarini M; Cavallaro T; Cabrini I; Cerini R; Bertolasi L; Rizzuto N
    Neurology; 2007 Jul; 69(3):291-5. PubMed ID: 17636067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
    González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
    Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients.
    Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z
    Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of IL7R exon 6 in acute leukemias and solid cancers.
    Kim MS; Chung NG; Kim MS; Yoo NJ; Lee SH
    Hum Pathol; 2013 Apr; 44(4):551-5. PubMed ID: 23069254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
    Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
    Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
    J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.
    Grossmann V; Kern W; Harbich S; Alpermann T; Jeromin S; Schnittger S; Haferlach C; Haferlach T; Kohlmann A
    Haematologica; 2011 Dec; 96(12):1874-7. PubMed ID: 21828118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
    Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
    Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
    Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
    Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.